CSIMarket
 
Cumberland Pharmaceuticals Inc   (NASDAQ: CPIX)
 
Price: $6.6900 $-1.77 -20.922%
Day's High: $8.5 Week Perf: -23.1 %
Day's Low: $ 6.60 30 Day Perf: 0.15 %
Volume (M): 190,347 52 Wk High: $ 9.28
Volume (M$): $ 0 52 Wk Avg: $4.41
Open: $8.21 52 Wk Low: $1.85



 Market Capitalization (Millions $) 100
 Shares Outstanding (Millions) 15
 Employees 93
 Revenues (TTM) (Millions $) 31
 Net Income (TTM) (Millions $) -11
 Cash Flow (TTM) (Millions $) -5
 Capital Exp. (TTM) (Millions $) 0

Business Description


Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company that is headquartered in Nashville, Tennessee. The company specializes in the development, marketing, and distribution of branded prescription products for the treatment of acute care, gastroenterology, oncology, pain management, and ophthalmology.

Cumberland Pharmaceuticals was founded in 1999 by A.J. Kazimi, who currently serves as the Chief Executive Officer of the company. Since its inception, the company has developed and launched multiple products in the market, including its flagship product, Acetadote, which is primarily used as an antidote to acetaminophen toxicity.

The company's product portfolio includes Caldolor, a non-steroidal anti-inflammatory drug used for pain management, Kristalose, a prescription laxative used for the treatment of constipation, Hepatoren, a prescription product used for the management of hepatic encephalopathy, and Ethyol, a product used to reduce certain side effects associated with chemotherapy and radiation.

Cumberland Pharmaceuticals has a robust research and development program that involves both internal research efforts and collaborations with other pharmaceutical companies and academic institutions. The company has also established distribution partnerships with some of the leading pharmaceutical companies in the world, including Merck, Sanofi, and Lupin.

The company operates in the United States and several international markets, including Europe, the Middle East, and Asia. In addition to its pharmaceutical business, Cumberland also has a medical products division that develops and markets medical accessories and devices used in the healthcare industry.

According to its latest financial reports, Cumberland Pharmaceuticals recorded sales of $99 million in 2020, up from $98 million in the previous year, and had a workforce of approximately 180 employees. The company has received several awards and recognitions for its innovation and contribution to the pharmaceutical industry, including being named one of the fastest-growing companies in the United States by Inc. Magazine.


   Company Address: 1600 West End Avenue Nashville 37203 TN
   Company Phone Number: 255-0068   Stock Exchange / Ticker: NASDAQ CPIX


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
ANIP   -1.24%    
• View Complete Report
   





Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 3.21
Price to Sales (Expected) -
Price to Book 5.75
PEG (TTM) -

Financial Strength Current
Quick Ratio 0.11
Working Capital Ratio 1.04
Leverage Ratio (MRQ) 2.61
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -0.74 $
Revenues (TTM) 2.09 $
Cash Flow (TTM) -
Cash 0.26 $
Book Value 1.16 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 336,224
Net Income per Employee (TTM) -117,625
Receivable Turnover Ratio (TTM) 2.27
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) 0.45

Profitability Ratios Current
Gross Margin (MRQ) 0 %
Operating Margin (MRQ) -1898.65 %
Net Margin (MRQ) -2567.87 %
Net Cash Flow Margin (MRQ) 0 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -



Cumberland Pharmaceuticals Inc's Segments
Product - Talicia    2569.88 % of total Revenue
Product - Sancuso    2323.49 % of total Revenue
Caldolor    639.16 % of total Revenue
Talicia    1469.88 % of total Revenue
Other revenue    234.94 % of total Revenue





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.